Skip to main content
. 2019 Jan 30;364:l42. doi: 10.1136/bmj.l42

Fig 2.

Fig 2

Review authors’ judgments about each risk of bias item, presented as percentages across all included studies. Grey area in the blinding of outcome assessment (objective outcomes) indicates that the domain was not applicable because some trials did not measure any eligible objective outcomes.